MERRIMACK PHARMACEUTICALS INC Proceeds from Stock Options Exercised
MERRIMACK PHARMACEUTICALS INC reported Proceeds from Stock Options Exercised of $1.49 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-05-15
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2024-03-31 was $1.49M, a 729.61% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2023-12-31 was $133.00K.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2023-09-30 was $0.00.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2023-06-30 was $209.00K.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2023 was $521.00K, a 92.03% decline from fiscal 2022.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2022 was $6.53M, a 2633.47% increase from fiscal 2021.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2021 was $239.00K.
- MERRIMACK PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2019 was $145.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-15 | $1.62M derived: sum of 2 quarters · filed 2024-05-15 | $1.62M derived: sum of 3 quarters · filed 2024-05-15 | $1.83M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $133.00K derived: sum of 2 quarters · filed 2024-03-07 | $342.00K derived: sum of 3 quarters · filed 2024-03-07 | $521.00K 10-K · filed 2024-03-07 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $209.00K derived: sum of 2 quarters · filed 2023-11-02 | $388.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $388.00K 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | $179.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $6.53M 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-09 | $239.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $239.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $239.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $239.00K 10-Q · filed 2022-05-05 | |||
| 2019-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $122.00K derived: sum of 2 quarters · filed 2021-03-10 | $145.00K 10-K · filed 2021-03-10 | |
| 2019-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $83.00K 10-Q · filed 2020-11-04 | ||
| 2019-06-30 | $23.00K 10-Q · filed 2020-08-07 | |||
| 2017-09-30 | $438.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.46M derived: sum of 2 quarters · filed 2018-11-07 | $6.52M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.08M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $4.05M 10-Q · filed 2018-05-08 | |||
| 2016-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.36M derived: sum of 2 quarters · filed 2017-11-08 | $4.01M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $953.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.60M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $1.65M 10-Q · filed 2017-05-10 |